Dual inhibition of BCR/ABL and KIT is required for suppression of mature CML progenitors, and the stem cell factor (SCF)/KIT pathway must be inhibited to enable apoptosis induced by BCR/ABL inhibitors in CML cells.4, 5. This evidence concerns the gene KITLG and chronic myelogenous leukemia, BCR-ABL1 positive.